Clinical Trial Update: TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting results for TPI-287 in patients with refractory or recurrent neuroblastoma or medulloblastoma. The study status is completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma
• Neuroblastoma

Drugs mentioned

• TPI-287

Snippet

Sponsor: Giselle Sholler | Conditions: Neuroblastoma, Medulloblastoma | Phase 1 | Status: COMPLETED | Results posted: 2016-10-28